Examination of the safety and the efficacy for patients using NP037 with chronic pain

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2032210400

Enrollment

Registered

2021-10-29

Start date

2021-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

Put on a probe of NP037 in the pain site and treatment.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged >=20 years at the time of consent, etc.

Exclusion criteria

Exclusion criteria: Patients whom an investigator or a sub-investigator judged to have difficulty in trial enforcement, etc.

Design outcomes

Primary

Measure	Time frame
Changes in VAS from first use to the end of the first use	—

Contacts

Public ContactMasako Kondo

Nipro Corporation

kondo-masako@nipro.co.jp+81-77-564-0500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026